Japanese encephalitis vaccines--needs, flaws and achievements. - Wikidata - wikimedia - TriplyDB

Japanese encephalitis vaccines--needs, flaws and achievements.

Japanese encephalitis vaccines--needs, flaws and achievements.

http://www.wikidata.org/entity/Q37309276

about

Past, Present, and Future of Japanese Encephalitis Development of a vaccine to prevent Japanese encephalitis: a brief review Data from the World Health Organization (WHO) National Network Laboratory for Japanese Encephalitis.Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization Evaluation of serological diagnostic test systems assessing the immune response to Japanese encephalitis vaccination.Emerging viral infections of the central nervous system: part 1.The incidence of Japanese encephalitis in Taiwan--a population-based study.Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strength

P2860

Q27488252-95EAD405-04C6-478F-8956-F36F1B8FBF54 Q27491289-29FC46D4-A87F-4963-8ED5-37215DE4645F Q30655304-0AE4549E-E187-470B-A7F3-21D8974B9773 Q33712740-1FDAF1F0-8F2E-45EC-91C5-0BB0F0FFD559 Q33754786-00CD53E0-1B99-4402-8F7D-116D71EEFD99 Q33866041-7007E215-F5D4-4950-989E-F8AF5D8DD76E Q33945553-9A22CCEB-FFCA-4C1F-985B-83D31F556195 Q34062468-D226C34C-E911-42EA-9BFC-92AD02CFC176

P2860

Japanese encephalitis vaccines--needs, flaws and achievements.

http://www.wikidata.org/entity/Q37309276

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Japanese encephalitis vaccines--needs, flaws and achievements.

@en

Japanese encephalitis vaccines--needs, flaws and achievements.

@nl

type

label

Japanese encephalitis vaccines--needs, flaws and achievements.

@en

Japanese encephalitis vaccines--needs, flaws and achievements.

@nl

prefLabel

Japanese encephalitis vaccines--needs, flaws and achievements.

@en

Japanese encephalitis vaccines--needs, flaws and achievements.

@nl

P1433

Q37309276-7B8A4637-C35B-48AB-96B8-76FD8A84CC18

P1476

Q37309276-17639B57-1B4F-4378-8CB1-BC8A0D6590C2

P2093

Q37309276-C652C1C4-1B93-480F-8EBA-88EEA5DC4870

P2860

Q37309276-18B2D70D-8878-456F-BC09-9654BE9F7396

Q37309276-230CB919-D1C9-4EAC-8452-62C9C8697BED

Q37309276-24FF5EF7-8A0E-4B9A-A706-063EE7C14A63

Q37309276-40FE6783-8143-4ECD-B633-0B62A5678CE3

Q37309276-49EAF03D-9C43-46BF-880E-38421533D5DD

Q37309276-507B9ED2-785B-4E46-83EF-6B29DA6068F7

Q37309276-5178A86D-1CDC-4969-9384-F250BA1A586A

Q37309276-6D29BA55-FF2B-497F-8C77-D58AB6C9CE1E

Q37309276-74D55376-8E8B-47AB-96F4-6D318A3B8E89

Q37309276-877BB915-725C-4727-858D-D0EEBF3A8D73

P304

Q37309276-F493856E-2FA4-4656-90B0-6DE83E4CDAF5

P31

Q37309276-7367AAA2-9DCA-4100-BA59-744959248BE5

P356

Q37309276-6F53F17F-177F-4E96-81CB-17C0F2C009F6

P433

Q37309276-84CE731E-7FD6-4900-889F-8B83F9ACEE53

P478

Q37309276-EBCE9C5F-B056-456C-8FF4-F33E4F955A0D

P50

Q37309276-D959F2B8-BCD6-4D4F-9CC7-DB1CB47545F6

P577

Q37309276-C86CE253-9B91-4D1F-B734-579D505F4D47

P698

Q37309276-08BDC96D-85C3-46D6-8B5F-83AE161E320A

P921

Q37309276-25D0945F-37DE-43E6-842D-64A66D5BFCB9

P356

P1433

Biological Chemistry

P1476

Japanese encephalitis vaccines--needs, flaws and achievements.

@en

P2093

Shailesh Dewasthaly

http://www.w3.org/2001/XMLSchema#string

P2860

Japanese encephalitis in a swedish tourist after travelling to Java and Bali.

Japanese encephalitis vaccine for travelers: exploring the limits of risk.

Behavioural disturbances following Japanese B encephalitis.

Live flavivirus vaccines: reasons for caution.

Flavivirus encephalitis.

Yellow fever and Japanese encephalitis vaccines: indications and complications.

Japanese encephalitis for a reference to international travelers.

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial.

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

Protection against Japanese encephalitis by inactivated vaccines.

P304

547-550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/BC.2008.062

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

389

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18953721

http://www.w3.org/2001/XMLSchema#string

P921

Japanese encephalitis virus